Induction of Colonic M Cells during Intestinal Inflammation

American Journal of Pathology

Volumn 186, Issue 5, 2016, Pages 1166-1179

  Bennett, Kaila M ^a,b   Parnell, Erinn A ^b   Sanscartier, Candice ^a,b   Parks, Sophia ^b   Chen, Gang ^b   Nair, Meera G ^b   Lo, David D ^b  

^a University of California Riverside   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXTRAN SULFATE; OSTEOCLAST DIFFERENTIATION FACTOR; TUMOR NECROSIS FACTOR ALPHA; CHEMOKINE RECEPTOR; CX3CR1 PROTEIN, MOUSE; CYTOKINE; IRRITANT AGENT; PGLYRP1 PROTEIN, MOUSE; TUMOR NECROSIS FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CITROBACTER RODENTIUM; CONTROLLED STUDY; ENTERITIS; EPITHELIUM CELL; INTESTINAL M CELL; INTESTINE CELL; LAMINA PROPRIA; LYMPHOID TISSUE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSCYTOSIS; ANIMAL; ANTAGONISTS AND INHIBITORS; BAGG ALBINO MOUSE; C57BL MOUSE; COLITIS; COLON; DISEASE MODEL; ENTEROBACTERIACEAE INFECTION; HUMAN; INTESTINE MUCOSA; METABOLISM; MICROVILLUS; PATHOLOGY; PATHOPHYSIOLOGY; PEYER PATCH; SCANNING ELECTRON MICROSCOPY; TRANSGENIC MOUSE; ULTRASTRUCTURE;

ANIMALS; CITROBACTER RODENTIUM; COLITIS; COLON; CYTOKINES; DEXTRAN SULFATE; DISEASE MODELS, ANIMAL; ENTEROBACTERIACEAE INFECTIONS; EPITHELIAL CELLS; HUMANS; INTESTINAL MUCOSA; IRRITANTS; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, TRANSGENIC; MICROSCOPY, ELECTRON, SCANNING; MICROVILLI; PEYER'S PATCHES; RECEPTORS, CHEMOKINE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84963997580     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2015.12.015     Document Type: Article

References (49)

1. J.P. Kraehenbuhl, and M.R. Neutra Epithelial M cells: differentiation and function Annu Rev Cell Dev Biol 16 2000 301 332
2. K.M. Bennett, S.L. Walker, and D.D. Lo Epithelial microvilli establish an electrostatic barrier to microbial adhesion Infect Immun 82 2014 2860 2871
3. M.H. Jang, M.-N. Kweon, K. Iwatani, M. Yamamoto, K. Terahara, C. Sasakawa, T. Suzuki, T. Nochi, Y. Yokota, P.D. Rennert, T. Hiroi, H. Tamagawa, H. Iijima, J. Kunisawa, Y. Yuki, and H. Kiyono Intestinal villous M cells: an antigen entry site in the mucosal epithelium Proc Natl Acad Sci U S A 101 2004 6110 6115
4. M.F.R. Vondenhoff, G. Kraal, and R.E. Mebius Lymphoid organogenesis in brief Eur J Immunol 37 Suppl 1 2007 S46 S52
5. S.N. Mueller, and R.N. Germain Stromal cell contributions to the homeostasis and functionality of the immune system Nat Rev Immunol 9 2009 618 629
6. S.-I. Nishikawa, K. Honda, P. Vieira, and H. Yoshida Organogenesis of peripheral lymphoid organs Immunol Rev 195 2003 72 80
7. K.A. Knoop, N. Kumar, B.R. Butler, S.K. Sakthivel, R.T. Taylor, T. Nochi, H. Akiba, H. Yagita, H. Kiyono, and I.R. Williams RANKL is necessary and sufficient to initiate development of antigen-sampling M cells in the intestinal epithelium J Immunol 183 2009 5738 5747
8. W. de Lau, P. Kujala, K. Schneeberger, S. Middendorp, V.S.W. Li, N. Barker, A. Martens, F. Hofhuis, R.P. DeKoter, P.J. Peters, E. Niewenhuis, and H. Clevers Peyer's patch M cells derived from Lgr5(+) stem cells require SpiB and are induced by RankL in cultured "miniguts." Mol Cell Biol 32 2012 3639 3647
9. H. Spits, D. Artis, M. Colonna, A. Diefenbach, J.P. Di Santo, G. Eberl, S. Koyasu, R.M. Locksley, A. McKenzie, R.E. Mebius, F. Powrie, and E. Vivier Innate lymphoid cells: a proposal for uniform nomenclature Nat Rev Immunol 13 2013 145 149
10. A. Gebert, S. Fassbender, K. Werner, and A. Weissferdt The development of M cells in Peyer's patches is restricted to specialized dome-associated crypts Am J Pathol 154 1999 1573 1582
11. J. Wang, M. Lopez-Fraga, A. Rynko, and D.D. Lo TNFR and LTbetaR agonists induce follicle-associated epithelium and M cell specific genes in rat and human intestinal epithelial cells Cytokine 47 2009 69 76
12. J. Wang, V. Gusti, A. Saraswati, and D.D. Lo Convergent and divergent development among M cell lineages in mouse mucosal epithelium J Immunol 187 2011 5277 5285
13. K. Terahara, M. Yoshida, O. Igarashi, T. Nochi, G.S. Pontes, K. Hase, H. Ohno, S. Kurokawa, M. Mejima, N. Takayama, Y. Yuki, A.W. Lowe, and H. Kyono Comprehensive gene expression profiling of Peyer's patch M cells, villous M-like cells, and intestinal epithelial cells J Immunol 180 2008 7840 7846
14. I.J. Fuss, M. Neurath, M. Boirivant, J.S. Klein, C. de la Motte, S.A. Strong, C. Fiocchi, and W. Strober Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5 J Immunol 157 1996 1261 1270
15. R.B. Sartor Mechanisms of disease: pathogenesis of Crohn's disease and ulcerative colitis Nat Clin Pract Gastroenterol Hepatol 3 2006 390 407
16. M. Maeda, N. Watanabe, H. Neda, N. Yamauchi, T. Okamoto, H. Sasaki, Y. Tsuji, S. Akiyama, N. Tsuji, and Y. Niitsu Serum tumor necrosis factor activity in inflammatory bowel disease Immunopharmacol Immunotoxicol 14 1992 451 461
17. E.J. Breese, C.A. Michie, S.W. Nicholls, S.H. Murch, C.B. Williams, P. Domizio, J.A. Walker-Smith, and T.T. MacDonald Tumor necrosis factor alpha-producing cells in the intestinal mucosa of children with inflammatory bowel disease Gastroenterology 106 1994 1455 1466
18. J.F. Colombel, W.J. Sandborn, W. Reinisch, G.J. Mantzaris, A. Kornbluth, D. Rachmilewitz, S. Lichtiger, G. D'Haens, R.H. Diamond, D.L. Broussard, K.L. Tang, C.J. van der Woude, P. Rutgeerts SONIC Study Group Infliximab, azathioprine, or combination therapy for Crohn's disease N Engl J Med 362 2010 1383 1395
19. W.J. Sandborn, C. Gasink, L.-L. Gao, M.A. Blank, J. Johanns, C. Guzzo, B.E. Sands, S.B. Hanauer, S. Targan, P. Rutgeerts, S. Ghosh, W.J.S. deVilliers, R. Panaccione, G. Greenberg, S. Schreiber, S. Lichtiger, B.G. Feagan CERTIFI Study Group Ustekinumab induction and maintenance therapy in refractory Crohn's disease N Engl J Med 367 2012 1519 1528
20. P.E. Dubé, S. Punit, and D.B. Polk Redeeming an old foe: protective as well as pathophysiological roles for tumor necrosis factor in inflammatory bowel disease Am J Physiol Gastrointest Liver Physiol 308 2015 G161 G170
21. I. Arijs, R. Quintens, L. Van Lommel, K. Van Steen, G. De Hertogh, K. Lemaire, A. Schraenen, C. Perrier, G. Van Assche, S. Vermeire, K. Geboes, F. Schuit, and P. Rutgeerts Predictive value of epithelial gene expression profiles for response to infliximab in Crohn's disease Inflamm Bowel Dis 16 2010 2090 2098
22. T.D. Walters, M.-O. Kim, L.A. Denson, A.M. Griffiths, M. Dubinsky, J. Markowitz, R. Baldassano, W. Crandall, J. Rosh, M. Pfefferkorn, A. Otley, M.B. Heyman, N. LeLeiko, S. Baker, S.L. Guthery, J. Evans, D. Ziring, R. Kellermayer, M. Stephens, D. Mack, M. Oliva-Hemker, A.S. Patel, B. Kirschner, D. Moulton, S. Cohen, S. Kim, C. Liu, J. Essers, S. Kugathasan, J.S. Hyams PRO-KIDS Research Group Increased effectiveness of early therapy with anti-tumor necrosis factor-α vs an immunomodulator in children with Crohn's disease Gastroenterology 146 2014 383 391
23. R. Dziarski, K.A. Platt, E. Gelius, H. Steiner, and D. Gupta Defect in neutrophil killing and increased susceptibility to infection with nonpathogenic gram-positive bacteria in peptidoglycan recognition protein-S (PGRP-S)-deficient mice Blood 102 2003 689 697
24. S. Jung, J. Aliberti, P. Graemmel, M.J. Sunshine, G.W. Kreutzberg, A. Sher, and D.R. Littman Analysis of fractalkine receptor CX(3)CR1 function by targeted deletion and green fluorescent protein reporter gene insertion Mol Cell Biol 20 2000 4106 4114
25. I. Okayasu, S. Hatakeyama, M. Yamada, T. Ohkusa, Y. Inagaki, and R. Nakaya A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice Gastroenterology 98 1990 694 702
26. C.G. Whittem, A.D. Williams, and C.S. Williams Murine colitis modeling using dextran sulfate sodium (DSS) J Vis Exp 2010 (35):pii:1652
27. L.C. Osborne, K.L. Joyce, T. Alenghat, G.F. Sonnenberg, P.R. Giacomin, Y. Du, K.S. Bergstrom, B.A. Vallance, and M.G. Nair Resistin-like molecule α promotes pathogenic Th17 cell responses and bacterial-induced intestinal inflammation J Immunol 190 2013 2292 2300
28. E. Viennois, F. Chen, H. Laroui, M.T. Baker, and D. Merlin Dextran sodium sulfate inhibits the activities of both polymerase and reverse transcriptase: lithium chloride purification, a rapid and efficient technique to purify RNA BMC Res Notes 6 2013 360
29. R.L. Owen, A.J. Piazza, and T.H. Ermak Ultrastructural and cytoarchitectural features of lymphoreticular organs in the colon and rectum of adult BALB/c mice Am J Anat 190 1991 10 18
30. M. Lochner Tertiary lymphoid tissues in the colon: friend and foe Gut Microbes 2 2011 193 197
31. A.P. Baptista, B.J. Olivier, G. Goverse, M. Greuter, M. Knippenberg, K. Kusser, R.G. Domingues, H. Veiga-Fernandes, A.D. Luster, A. Lugering, T.D. Randall, T. Cupedo, and R.E. Mebius Colonic patch and colonic SILT development are independent and differentially regulated events Mucosal Immunol 6 2013 511 521
32. R.L. Owen, and A.L. Jones Epithelial cell specialization within human Peyer's patches: an ultrastructural study of intestinal lymphoid follicles Gastroenterology 66 1974 189 203
33. P.J. Giannasca, K.T. Giannasca, P. Falk, J.I. Gordon, and M.R. Neutra Regional differences in glycoconjugates of intestinal M cells in mice: potential targets for mucosal vaccines Am J Physiol 267 6 Pt 1 1994 G1108 G1121
34. P.J. Giannasca, K.T. Giannasca, A.M. Leichtner, and M.R. Neutra Human intestinal M cells display the sialyl Lewis A antigen Infect Immun 67 1999 946 953
35. J. Pappo Generation and characterization of monoclonal antibodies recognizing follicle epithelial M cells in rabbit gut-associated lymphoid tissues Cell Immunol 120 1989 31 41
36. S. Yu, and A.W. Lowe The pancreatic zymogen granule membrane protein, GP2, binds Escherichia coli Type 1 fimbriae BMC Gastroenterol 9 2009 58
37. D. Lo, W. Tynan, J. Dickerson, J. Mendy, H.-W. Chang, M. Scharf, D. Byrne, D. Brayden, L. Higgins, C. Evans, and D.J. O'Mahony Peptidoglycan recognition protein expression in mouse Peyer's Patch follicle associated epithelium suggests functional specialization Cell Immunol 224 2003 8 16
38. L. Jostins, S. Ripke, R.K. Weersma, R.H. Duerr, D.P. McGovern, K.Y. Hui, and et al. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease Nature 491 2012 119 124
39. J.B. Kaper, J.P. Nataro, and H.L. Mobley Pathogenic Escherichia coli Nat Rev Microbiol 2 2004 123 140
40. K. Geddes, S.J. Rubino, J.G. Magalhaes, C. Streutker, L. Le Bourhis, J.H. Cho, S.J. Robertson, C.J. Kim, R. Kaul, D.J. Philpott, and S.E. Girardin Identification of an innate T helper type 17 response to intestinal bacterial pathogens Nat Med 17 2011 837 844
41. J.W. Collins, C. Chervaux, B. Raymond, M. Derrien, R. Brazeilles, A. Kosta, I. Chambaud, V.F. Crepin, and G. Frankel Fermented dairy products modulate Citrobacter rodentium-induced colonic hyperplasia J Infect Dis 210 2014 1029 1041
42. M.A. Clark, B.H. Hirst, and M.A. Jepson M-cell surface beta1 integrin expression and invasin-mediated targeting of Yersinia pseudotuberculosis to mouse Peyer's patch M cells Infect Immun 66 1998 1237 1243
43. T.V. Golovkina, M. Shlomchik, L. Hannum, and A. Chervonsky Organogenic role of B lymphocytes in mucosal immunity Science 286 1999 1965 1968
44. E.H. Hsieh, X. Fernandez, J. Wang, M. Hamer, S. Calvillo, M. Croft, B.S. Kwon, and D.D. Lo CD137 is required for M cell functional maturation but not lineage commitment Am J Pathol 177 2010 666 676
45. A. Kratz, A. Campos-Neto, M.S. Hanson, and N.H. Ruddle Chronic inflammation caused by lymphotoxin is lymphoid neogenesis J Exp Med 183 1996 1461 1472
46. H.A. Arnett, J. Mason, M. Marino, K. Suzuki, G.K. Matsushima, and J.P. Ting TNF alpha promotes proliferation of oligodendrocyte progenitors and remyelination Nat Neurosci 4 2001 1116 1122
47. The Lenercept Multiple Sclerosis Study Group and The University of British Columbia MS/MRI Analysis Group: TNF neutralization in MS: results of a randomized, placebo-controlled multicenter study Neurology 53 1999 457 465
48. B.W. van Oosten, F. Barkhof, L. Truyen, J.B. Boringa, F.W. Bertelsmann, B.M. von Blomberg, J.N. Woody, H.P. Hartung, and C.H. Polman Increased MRI activity and immune activation in two multiple sclerosis patients treated with the monoclonal anti-tumor necrosis factor antibody cA2 Neurology 47 1996 1531 1534
49. A.P. Gregory, C.A. Dendrou, K.E. Attfield, A. Haghikia, D.K. Xifara, F. Butter, G. Poschmann, G. Kaur, L. Lambert, O.A. Leach, S. Promel, D. Punwani, J.H. Felce, S.J. Davis, R. Gold, F.C. Nielsen, R.M. Siegel, M. Mann, J.I. Bell, G. McVean, and L. Fugger TNF receptor 1 genetic risk mirrors outcome of anti-TNF therapy in multiple sclerosis Nature 488 2012 508 511